TARCEVA 150 mg, comprimé pelliculé — plaquette(s) thermoformée(s) PVC-Aluminium de 30 comprimé(s)
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400936923522 -
CIP7
3692352 -
CIS
63390528 -
Registration number
EU/1/05/311
What the source publishes
- Holder
- CHEPLAPHARM REGISTRATION (ALLEMAGNE)
- Active ingredients
- ERLOTINIB (CHLORHYDRATE D'), ERLOTINIB
- Form
- comprimé pelliculé
- Package
- plaquette(s) thermoformée(s) PVC-Aluminium de 30 comprimé(s)
- Routes
- orale
- Administrative status
- authorised
- Supply regime
- médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2005-09-19
- Prescription
- Prescription or restricted
Names this record is found by
- TARCEVA 150 mg, comprimé pelliculé — plaquette(s) thermoformée(s) PVC-Aluminium de 30 comprimé(s)
- TARCEVA 150 mg, comprimé pelliculé
- ERLOTINIB (CHLORHYDRATE D')
- ERLOTINIB
Complete source data
{
"cis": "63390528",
"cip7": "3692352",
"form": "comprimé pelliculé",
"name": "TARCEVA 150 mg, comprimé pelliculé — plaquette(s) thermoformée(s) PVC-Aluminium de 30 comprimé(s)",
"cip13": "3400936923522",
"holder": "CHEPLAPHARM REGISTRATION (ALLEMAGNE)",
"routes": [
"orale"
],
"holders": [
"CHEPLAPHARM REGISTRATION (ALLEMAGNE)"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "1666.68",
"authorisedOn": "2005-09-19",
"compositions": [
{
"name": "ERLOTINIB (CHLORHYDRATE D')",
"nature": "SA",
"strength": null,
"linkageNumber": "1",
"substanceCode": "27387",
"dosageReference": null,
"pharmaceuticalElement": "comprimé"
},
{
"name": "ERLOTINIB",
"nature": "FT",
"strength": "150 mg",
"linkageNumber": "1",
"substanceCode": "56421",
"dosageReference": "un comprimé",
"pharmaceuticalElement": "comprimé"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE",
"dispensingFee": "1.02",
"medicinePrice": "1665.66",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "TARCEVA 150 mg, comprimé pelliculé",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-11-20",
"CIS_CIP_bdpm": "2026-11-20",
"CIS_CPD_bdpm": "2026-11-20",
"CIS_COMPO_bdpm": "2026-11-20"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "plaquette(s) thermoformée(s) PVC-Aluminium de 30 comprimé(s)",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"100%"
],
"marketingDeclaredOn": "2005-11-28",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"ERLOTINIB (CHLORHYDRATE D')",
"ERLOTINIB"
],
"authorisationProcedure": "Procédure centralisée",
"prescriptionConditions": [
"médicament nécessitant une surveillance particulière pendant le traitement",
"prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE",
"prescription réservée aux spécialistes et services HEMATOLOGIE",
"prescription hospitalière",
"liste I",
"prescription réservée aux médecins compétents en CANCEROLOGIE"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": "EU/1/05/311",
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400936923522"